Skip to main content
. Author manuscript; available in PMC: 2008 Feb 13.
Published in final edited form as: J Dent Res. 2006 Jun;85(6):542–546. doi: 10.1177/154405910608500612

Table 3.

Association of Observed Polymorphism with Orofacial Clefting with or without Tooth Agenesis

Nucleotide
Positiona
Nucleotide
Variant
Amino
Acid
Variant
Case-Control Comparisons Controlsd,
N = 165
Clefting (CL/P), n = 33* Clefting and Tooth Agenesisb, n = 19 Clefting and Tooth Agenesisc, n = 13
Number of Variantse (%) p value Number of Variantse (%) p value Number of Variantse (%) p value
5′UTR
434 −36G>A - 4/66 ( 6.1%) 0.22 0/38 ( 0%) 0.11 0/38 ( 0%) 0.11 20/330 ( 6.1%)
EXON 1
570 101C>G Ala34Gly 12/66 (18.2%) 0.14 16/38 (42.1%) 0.0008 9/26 (34.6%) 0.028 60/330 (18.2%)
799 330C>T Gly110Gly 3/66 ( 4.5%) 0.11 0/38 ( 0%) 0.56 0/38 ( 0%) 0.56 5/318 ( 1.6%)
3′UTR
3695 *6C>T - 30/66 (45.4%) 0.001 4/38 (10.5%) 0.014 2/26 ( 7.7%) 0.017 66/248 (26.6%)
*

n = number of individuals included in the analysis.

a

Positions of variants are referred to by the nucleotide position within the GenBank entry, AF426432.

b

Analysis included 19 individuals with clefting and tooth agenesis.

c

Analysis excluded six individuals with clefting, tooth agenesis, and additional major anomalies or facial dysmorphology.

d

Control data from Lidral et al. (1998).

e

Number of variants is number of chromosomes for rare allele/total number of alleles.